PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.\', \'Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.\', \'James J. Peters VA Medical Center, Bronx, New York, USA.\', \'Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.\', \'Department of Microbiology and Immunology, Louisiana State University Health Science Center Shreveport, Shreveport, Louisiana, USA.\', \'COVIDAR Argentina Consortium, Buenos Aires, Argentina.\', \'Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA Benhur.Lee@mssm.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e02492-2010.1128/mBio.02492-20
?:hasPublicationType
?:journal
  • mBio
is ?:pmid of
?:pmid
?:pmid
  • 33593976
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.106
?:rankingScore_hIndex
  • 71
?:title
  • Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all